IMPACT OF NON-ORAL AMPHOTERICIN B ON THE PREVENTION OFASPERGILLUS INFECTIONS IN NEUTROPENIC PATIENTS

0E+0

standard

bmt

low dose

ampho B i.v.

ampho B aerosol

%

Previous slide

Next slide

Back to first slide

View graphic version